Back to Search
JULIA TOKARSKI, MD
MD
Pediatric Emergency Medicine (Emergency Medicine) Physician
NPI: 1326320722Individual
Specialties, Licenses & Credentials
Pediatric Emergency Medicine (Emergency Medicine) PhysicianPrimary
Emergency Medicine — Pediatric Emergency Medicine
Code: 207PP0204X
269655(NY)
Research & Publications (20)
The structure of Dasatinib (BMS-354825) bound to activated ABL kinase domain elucidates its inhibitory activity against imatinib-resistant ABL mutants.
PMID 16740718·Cancer Res·2006
7-preclinical
Discovery of N-(4-(2-amino-3-chloropyridin-4-yloxy)-3-fluorophenyl)-4-ethoxy-1-(4-fluorophenyl)-2-oxo-1,2-dihydropyridine-3-carboxamide (BMS-777607), a selective and orally efficacious inhibitor of the Met kinase superfamily.
PMID 19260711·J Med Chem·2009
7-preclinical
Small doses of morphine can enhance NK cell cytotoxicity in pigs.
PMID 19059365·Int Immunopharmacol·2009
7-preclinical
Discovery of orally active pyrrolopyridine- and aminopyridine-based Met kinase inhibitors.
PMID 18479916·Bioorg Med Chem Lett·2008
7-preclinical
Identification of pyrrolo[2,1-f][1,2,4]triazine-based inhibitors of Met kinase.
PMID 18289854·Bioorg Med Chem Lett·2008
7-preclinical
Synthesis, SAR, and Evaluation of 4-[2,4-Difluoro-5-(cyclopropylcarbamoyl)phenylamino]pyrrolo[2,1-f][1,2,4]triazine-based VEGFR-2 kinase inhibitors.
PMID 18221875·Bioorg Med Chem Lett·2008
7-preclinical
Identification of 2-amino-5-(thioaryl)thiazoles as inhibitors of nerve growth factor receptor TrkA.
PMID 18055203·Bioorg Med Chem Lett·2008
8-other
Design, synthesis, and anti-inflammatory properties of orally active 4-(phenylamino)-pyrrolo[2,1-f][1,2,4]triazine p38alpha mitogen-activated protein kinase inhibitors.
PMID 18072718·J Med Chem·2008
7-preclinical
Multiple and single binding modes of fragment-like kinase inhibitors revealed by molecular modeling, residue type-selective protonation, and nuclear overhauser effects.
PMID 18771253·J Med Chem·2008
8-other
Discovery of pyrrolopyridine-pyridone based inhibitors of Met kinase: synthesis, X-ray crystallographic analysis, and biological activities.
PMID 18690676·J Med Chem·2008
7-preclinical
5-((4-Aminopiperidin-1-yl)methyl)pyrrolotriazine dual inhibitors of EGFR and HER2 protein tyrosine kinases.
PMID 17606372·Bioorg Med Chem Lett·2007
7-preclinical
Novel C-5 aminomethyl pyrrolotriazine dual inhibitors of EGFR and HER2 protein tyrosine kinases.
PMID 17368025·Bioorg Med Chem Lett·2007
7-preclinical
New C-5 substituted pyrrolotriazine dual inhibitors of EGFR and HER2 protein tyrosine kinases.
PMID 17270437·Bioorg Med Chem Lett·2007
7-preclinical
Amphetamine enhances natural killer cytotoxic activity via beta-adrenergic mechanism.
PMID 17244944·J Physiol Pharmacol·2006
7-preclinical
Stress-induced enhancement of activity of lymphocyte lysosomal enzymes in pigs of different stress-susceptibility.
PMID 17242473·J Physiol Pharmacol·2006
7-preclinical
Discovery and evaluation of N-cyclopropyl- 2,4-difluoro-5-((2-(pyridin-2-ylamino)thiazol-5- ylmethyl)amino)benzamide (BMS-605541), a selective and orally efficacious inhibitor of vascular endothelial growth factor receptor-2.
PMID 16789733·J Med Chem·2006
7-preclinical
Identification of a novel series of tetrahydrodibenzazocines as inhibitors of 17beta-hydroxysteroid dehydrogenase type 3.
PMID 16386902·Bioorg Med Chem Lett·2006
8-other
Synthesis and SAR of 4-(3-hydroxyphenylamino)pyrrolo[2,1-f][1,2,4]triazine based VEGFR-2 kinase inhibitors.
PMID 15713401·Bioorg Med Chem Lett·2005
7-preclinical
New dual inhibitors of EGFR and HER2 protein tyrosine kinases.
PMID 16111887·Bioorg Med Chem Lett·2005
8-other
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 1468 MADISON AVE
NEW YORK, NY 10029 - Phone
- (212) 241-7151
Quick Facts
- NPI
- 1326320722
- Entity Type
- Individual
- Gender
- Female
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 1
- Publications
- 20
Are you this provider?
Claim Your Profile